Publication | Closed Access

Effect of Intravenous Ascorbic Acid in Hemodialysis Patients With EPO-Hyporesponsive Anemia and Hyperferritinemia

HemodialysisUrologyRenal FunctionHemodialysis PatientsMedicineHematologyDialysis TherapyMetabolismChronic Kidney DiseaseNephrologyEpo-hyporesponsive AnemiaIntravenous Ascorbic Acid